Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer

Title
Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer
Authors
Keywords
-
Journal
Science Signaling
Volume 10, Issue 462, Pages eaal2328
Publisher
American Association for the Advancement of Science (AAAS)
Online
2017-01-18
DOI
10.1126/scisignal.aal2328

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search